0 items USD 0.00Search
- Did you mean
- biosimilar
Your search for "biosimilars" gave back 1017 results.
Ranibizumab, sold under the brand name Lucentis among others, is a monoclonal antibody fragment (Fab) created from the same parent mouse antibody as...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
The global Avastin Biosimilar market size is expected to reach $ 484.9 million by 2029, rising at a market growth of -13.9% CAGR during the forecast...
Catalog:
GIR
June 2023
Price: USD 4,480.00
Peptides are short chains of amino acid monomers linked by peptide (amide) bonds. The statistic scope in this report is peptides biosimilars. The...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Glycosylated Biosimilars include mA, EPO etc in this report. The global Glycosylated Biosimilars market is projected to reach US$ million in 2029,...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Humira is a tumor necrosis factor (TNF) blocker that reduces the effects of a substance in the body that can cause inflammation. The global Humira...
Catalog:
MRRPB5
June 2023
Price: USD 2,900.00
The global Humira Biosimilar market size is expected to reach $ 955.4 million by 2029, rising at a market growth of 12.0% CAGR during the forecast...
Catalog:
GIR
June 2023
Price: USD 4,480.00
A biosimilar medicine is a medicinal product of biological origin that is produced in a living organism following a procedure equivalent to a...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
The global Thyrogen and Biosimilar market size is expected to reach $ 703.3 million by 2029, rising at a market growth of 15.0% CAGR during the...
Catalog:
GIR
June 2023
Price: USD 4,480.00
The global Epogen and Biosimilar market size is expected to reach $ 593.8 million by 2029, rising at a market growth of -3.0% CAGR during the...
Catalog:
GIR
June 2023
Price: USD 4,480.00
Omalizumab is a medication used to treat asthma, nasal polyps, and urticaria. Omalizumab is a recombinant DNA-derived humanized IgG1k monoclonal...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
Brolucizumab is a humanized single-chain antibody fragment for the treatment of neovascular (wet) age-related macular degeneration (AMD). The most...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
The global Herceptin (Trastuzumab) and Biosimilar market size is expected to reach $ 6357.7 million by 2029, rising at a market growth of 4.6% CAGR...
Catalog:
GIR
June 2023
Price: USD 4,480.00
A biosimilar is a biologic medical product highly similar to another already approved biological medicine (the 'reference medicine')...
Catalog:
MRRPB5
May 2023
Price: USD 4,900.00
The global Lucentis (Ranibizumab) and Biosimilar market size is expected to reach $ 971.5 million by 2029, rising at a market growth of -2.5% CAGR...
Catalog:
GIR
June 2023
Price: USD 4,480.00
The global Enbrel (Etanercept) Biosimilar market size is expected to reach $ 1732.5 million by 2029, rising at a market growth of 4.4% CAGR during...
Catalog:
GIR
June 2023
Price: USD 4,480.00
